Append Medical

Series-A
appendmedical.com Biotech & Healthcare
Total Funding $4.3M
Latest Round $4.3M Series-A
Last Announced Jul 6, 2023
Investors Undisclosed
Decision Makers 5 Available

About Append Medical

A novel transcatheter LAA occlusion—safe, fast, and effective. Minimizes stroke risk, eliminates DRT and PDL, and reduces reliance on blood thinners and anticoagulants

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website appendmedical.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $4,350,000 · Series-A

    news.google.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Append Medical.

Funding History

1 Round
Series-A equity · Jul 6, 2023

Founders & Leadership

1

Zachi Berger

Founder and Observer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts